Finally, insulin and Aβ are both substrates of insulin-degrading enzyme and it has been suggested that hyperinsulinemia inhibits the degradation of Aβ by competitively blocking insulin-degrading enzyme [50]. The gene discussed is INS; the disease is hyperinsulinism.